Immunogenic Profiling Reveals Promising RV-Identified Antigens as Vaccine Candidates Against Klebsiella pneumoniae
International Journal of Molecular Sciences · 18.07.2026 · 27 (14) · 6398
DOI: 10.3390/ijms27146398 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.07.2026. Verfasst von Ana Tajuelo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Intrahospital Infections Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain. Hauptthemen laut MEDLINE: Antigens, Bacterial, Klebsiella pneumoniae, Bacterial Outer Membrane Proteins, Bacterial Vaccines. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, FPU grant.
Abstract (Originalsprache)
Multidrug-resistant Klebsiella pneumoniae is an increasing global threat, and the limited availability of new antibiotics highlights vaccination as a promising strategy for infection prevention. Although different vaccine candidates have been evaluated, none is currently approved, mainly due to capsular heterogeneity among strains. Protein-based vaccines may overcome this limitation by targeting conserved epitopes. In this study, we assessed the immunogenicity of five outer membrane proteins (ChiP, LamB, RafY, OmpW, PagP) previously selected by reverse vaccinology (RV), comparing them with the well-characterized antigens OmpA and OmpK36. Mice were immunized intramuscularly with three doses of purified recombinant proteins, and antibody responses were analyzed by ELISA. All antigens elicited high, booster-induced IgG levels, with PagP slightly being less immunogenic. Regarding IgG subclasses, IgG1 predominated, followed by IgG2b and IgG2c. Cross-reactivity was evaluated against six K. pneumoniae strains representing different clonal groups, and recognition by sera from previously infected mice was also examined. OmpA, ChiP and LamB showed the broadest cross-reactivity, while OmpA and LamB were most strongly recognized after infection. Overall, OmpA, LamB, ChiP and RafY emerged as the most promising vaccine candidates, although further optimization, such as a multicomponent vaccine, may be required. This work also highlights the importance of experimentally validating RV-selected antigens, as computational predictions alone do not ensure immunogenicity or in vivo relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intrahospital Infections Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
- Programa de Doctorado en Ciencias Biomédicas y Salud Pública, IMIENS, Universidad Nacional de Educación a Distancia (UNED), 28015 Madrid, Spain.
- Core Scientific and Technical Units, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
- Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.
ORCID-Profile: Ana Tajuelo, Beatriz Cano-Castaño, Sonia Prieto Martín-Gil, Pedro Miguela-Villoldo, Astrid Pérez
Förderung
- Instituto de Salud Carlos III
- FPU grant
Zitieren
APA
Tajuelo, A., Gato, E., Vaughan, L., Cano-Castaño, B., Martín-Gil, S. P., Miguela-Villoldo, P., Martín-Galiano, A. J., McConnell, M. J., & Pérez, A. (2026). Immunogenic Profiling Reveals Promising RV-Identified Antigens as Vaccine Candidates Against Klebsiella pneumoniae. International Journal of Molecular Sciences, 27(14), 6398. https://doi.org/10.3390/ijms27146398
Vancouver
Tajuelo A, Gato E, Vaughan L, Cano-Castaño B, Martín-Gil SP, Miguela-Villoldo P, et al. Immunogenic Profiling Reveals Promising RV-Identified Antigens as Vaccine Candidates Against Klebsiella pneumoniae. International Journal of Molecular Sciences. 2026;27(14):6398. doi:10.3390/ijms27146398
BibTeX
@article{Tajuelo2026,
author = {Tajuelo, Ana and Gato, Eva and Vaughan, Leilani and Cano-Castaño, Beatriz and Martín-Gil, Sonia Prieto and Miguela-Villoldo, Pedro and Martín-Galiano, Antonio J and McConnell, Michael J and Pérez, Astrid},
title = {Immunogenic Profiling Reveals Promising RV-Identified Antigens as Vaccine Candidates Against Klebsiella pneumoniae},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6398},
doi = {10.3390/ijms27146398}
}
EUVIMED